COSCIENS Biopharma Inc.

C$8.50As of Sun 8 Nov 2026, 12:00 UTC
TSX:CSCIHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (40.51%)
Div yield —
ROE (52.83%)
Biotechnology
Beta (5Y) 1.91
PE TTM 0.962
TSR TTM (18.82%)
Mkt cap C$8.476M
ROIC (52.03%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.42
10.77%
(31.43%)
Hold 11|1|2|12|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.14
0.15
0.17
0.16
9.15%
5.80%
19.53%
17.25%
Revenue$M
0.410
0.433
0.454
0.470
5.67%
8.36%
11.96%
18.29%
Peers (US$6.000M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.254
5.695
4.043
EBIT/Intx
0.330
0.135
0.135
Own earn%
29.06
100.26
93.35
Sh yield%
22.72
18.31
16.51
Owners
Insiders/Inst%
10.68
48.11
Short interest%
2.26
SBC / revenue%
3.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
16–24
$1 testx
0.0
Incr. ROIC%
3